Biebergemünd, Germany

Peter Langguth

This inventor holds 3 USPTO granted patents, plus 2 CIPO patents and 1 EPO patent. Top assignees: Evonik Roehm Gmbh, Merck Patent Gmbh. Active years: 2012-2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Peter Langguth. Retrieved from https://idiyas.com/inventor/peter-langguth-wnzugyio

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


 

 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Location History:

  • Biebergemünd, DE (2012)
  • Mainz, DE (2012)
  • Biebergemuend, DE (2013)

Company Filing History:


Years Active: 2012-2013

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovator Spotlight - Peter Langguth

Introduction

Peter Langguth is a notable inventor based in Biebergemünd, Germany, whose work in pharmaceutical formulations has led to the development of innovative solutions aimed at enhancing drug delivery. With a total of two patents to his name, Langguth's inventions focus on improving the permeability and solubility of active substances in pharmaceuticals, making significant strides in the healthcare industry.

Latest Patents

Langguth's latest patents reflect his dedication to advancing pharmaceutical sciences. The first patent, titled "Quaternization of the additive amino alkylmethacrylate copolymer E for improving permeability and solubility of pharmaceuticals," provides a method for chemically modifying a copolymer to enhance drug absorption. This innovation presents a novel strategy for overcoming challenges related to the solubility of various pharmaceuticals.

The second patent, "Multiparticle pharmaceutical dosage form for low-soluble active substances and method for producing said pharmaceutical dosage form," describes a unique oral dosage form designed to maintain effective pH levels in the stomach. The invention details a multiparticle structure that not only addresses the solubility of low-soluble active ingredients but also incorporates a mucoadhesive layer to aid in the drug’s delivery and effectiveness.

Career Highlights

Peter Langguth currently works with Evonik Röhm GmbH, a global leader in specialty chemicals. His role in the company allows him to contribute to groundbreaking research and development initiatives aimed at creating more effective pharmaceutical solutions. Langguth's work is underscored by a strong commitment to innovation, demonstrating his ability to address complex problems within the pharmaceutical field.

Collaborations

Throughout his career, Langguth has collaborated with esteemed colleagues such as Rosario Lizio and Hans-Ulrich Petereit. Working alongside talented professionals enables him to incorporate diverse perspectives and expertise into his projects, further enhancing the quality and impact of his inventions.

Conclusion

Peter Langguth's contributions to the field of pharmaceuticals through his patents exemplify the spirit of innovation. His efforts in creating enhanced drug formulations not only benefit patients but also pave the way for future advancements in medical science. As he continues to collaborate and innovate, Langguth remains a key figure in the pursuit of effective healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…